EGF Receptor Endocytosis: Mechanisms and Role in Signaling
EGF Receptor Endocytosis: Mechanisms and Role in Signaling
批准号:
10552100
负责人:
ALEXANDER D SORKIN
金额:
$39.75万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2028-03-31
关键词:
ActinsAddressAdultBiological AssayCellsCellular AssayChimeric ProteinsClathrinComplexDevelopmentEndocytosisEndosomesEnzymesEpidermal Growth Factor ReceptorEukaryotaFamilyFluorescenceFundingGene FusionGenerationsGenesHomeostasisHuman PathologyLabelLigandsMass Spectrum AnalysisMeasuresMediatingMethodsModelingMolecularMonitorNational Institute of General Medical SciencesPathologyPathway interactionsPlayPositioning AttributeProcessProteinsProteomeReceptor Protein-Tyrosine KinasesReceptor SignalingRegulationResearchRoleSignal PathwaySignal TransductionSortingStressVAV2 geneVesiclecarcinogenesisexperimental studyin vivometastatic processnovelnovel strategiesp38 Mitogen Activated Protein Kinasephosphoproteomicsratiometricscreeningspatiotemporaltemporal measurementtissue regenerationtraffickingwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Signaling by receptor tyrosine kinases (RTK) controls major vital processes in developing and adult eukaryotes
and is involved in a variety of human pathologies. Epidermal growth factor receptor (EGFR) is the classic RTK,
whose signaling and trafficking have been extensively studied, but the molecular mechanisms of endocytosis
and spatiotemporal regulation of signaling processes by endocytosis remain poorly understood. Fundamental
questions of whether signaling is triggered from endosomes by internalized EGFR and how such signaling is
regulated by the endosomal sorting machinery are not addressed. Reciprocally, whether EGFR signaling
regulates endocytic trafficking machinery, remains sparsely studied and controversial. Further, the degree and
rates of the incorporation of EGFR signaling complexes into intralumenal vesicles of multivesicular endosomes,
a process that terminates signaling, are also unknown. In the NIGMS funded research, we have developed
single-cell and high-throughput methods to quantitatively monitor endocytic trafficking of endogenous gene-
edited EGFR using a pH-sensitive ratiometric fluorescence excitation model. We used these methods to
elucidate the mechanism of EGFR endocytosis caused by activation of stress-induced p38-MAP kinase and to
determine mechanisms of the crosstalk of this pathway with ligand-induced endocytic pathways. We have
developed a pipeline for generation of gene-edited cells expressing endogenous fluorescently tagged EGFR and
its downstream signaling effectors, and new approaches to examine the dynamics of these components at high
spatial and temporal resolution in living cells. We performed comprehensive phosphoproteomic and proximity
proteome mass-spectrometry screenings to identify signaling effectors and regulators of endosomal EGFR.
Finally, our preliminary experiments using a novel live-cell assay prompted us to hypothesize that EGFR:adaptor
complexes are rapidly incorporated into intralumenal vesicles of multivesicular endosomes which diminishes the
capacity of those complexes to signal. These advances have placed us in a unique position to fully define
molecular mechanisms of clathrin-mediated internalization of EGFR, an endocytic pathway of EGFR in vivo, and
address key fundamental questions of whether EGFR signals from endosomes and how this signaling is
terminated. We will exploit the discoveries of the endosomal localization of an actin regulator VAV2 and a protein
of uncertain function, TFG (Trk-gene fusion protein), to define their functions in EGFR signaling from endosomes.
Using our new assay measuring distribution of signaling complexes within multivesicular endosomes in living
cells, we will determine the dynamics of the termination of signaling from endosomal EGFR complexed with
various endogenous fluorescently labeled adaptors and enzymes. Together, proposed studies will lead to a
comprehensive understanding of the mechanisms of endocytosis and spatiotemporal regulation of signaling
processes by endocytosis, and will serve as a paradigm to a similar analysis of the whole RTK family.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Admin Supplement - Pathogenesis of Cancer - Role of EGF Receptor Endocytos
-
批准号:10621504
-
项目类别:
-
资助金额:$3.53万
-
财政年份:2022
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Administrative Supplement-Signaling by the EGF Receptor from Endosomes
-
批准号:10381939
-
项目类别:
-
资助金额:$13.77万
-
财政年份:2017
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Signaling by the EGF Receptor from Endosomes
-
批准号:10004683
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2017
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of cancer: Role of EGF receptor endocytosis
-
批准号:9906352
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2012
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of cancer: Role of EGF receptor endocytosis
-
批准号:8676443
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2012
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of cancer: Role of EGF receptor endocytosis
-
批准号:8509610
-
项目类别:
-
资助金额:$31.48万
-
财政年份:2012
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of cancer: Role of EGF receptor endocytosis
-
批准号:8233791
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2012
-
负责人:ALEXANDER D SORKIN
-
依托单位:
EGF Receptor Signaling in Time and Space in Tumor Cells
-
批准号:8075166
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2009
-
负责人:ALEXANDER D SORKIN
-
依托单位:
EGF Receptor Signaling in Time and Space in Tumor Cells
-
批准号:7579326
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2009
-
负责人:ALEXANDER D SORKIN
-
依托单位:
EGF Receptor Signaling in Time and Space in Tumor Cells
-
批准号:8265322
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2009
-
负责人:ALEXANDER D SORKIN
-
依托单位:
EGF Receptor Signaling in Time and Space in Tumor Cells
-
批准号:8193119
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2009
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of Cancer - Role of EGF Receptor Endocytosis
-
批准号:10684728
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of Cancer - Role of EGF Receptor Endocytosis
-
批准号:7546584
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Dopamine Transporter Regulation by Endocytosis
-
批准号:6323216
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
PATHOGENESIS OF CANCER--ROLE OF EGF RECEPTOR ENDOCYTOSIS
-
批准号:6693360
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of Cancer - Role of EGF Receptor Endocytosis
-
批准号:7197294
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Dopamine Transporter Regulation by Endocytosis
-
批准号:6634371
-
项目类别:
-
资助金额:$29.57万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Pathogenesis of Cancer - Role of EGF Receptor Endocytosis
-
批准号:8313001
-
项目类别:
-
资助金额:$3.33万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
PATHOGENESIS OF CANCER--ROLE OF EGF RECEPTOR ENDOCYTOSIS
-
批准号:6228776
-
项目类别:
-
资助金额:$23.78万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
Dopamine Transporter Regulation by Endocytosis
-
批准号:8462579
-
项目类别:
-
资助金额:$32.8万
-
财政年份:2001
-
负责人:ALEXANDER D SORKIN
-
依托单位:
海外基金